Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood

Clinical trial NCT00616772 · COMPLETED

Trial details

NCT number: NCT00616772
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Disease Coronary Heart Disease Dyslipidemia

Start date: 2008-02-01
Primary completion: 2012-09-01
Enrollment: 682

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.